Remimazolam benzenesulfonate

CAS No. : 1001415-66-2

Remimazolam benzenesulfonate,1001415-66-2
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000073
Molecular Formula:C27H25BrN4O5S
Molecular Weight:597.48
Target:GABA Receptor
Price:Get quote
We match the lowest price on market.

Your information is safe with us.

Cat No:I000073
Cas No:1001415-66-2
Product-Name:Remimazolam benzenesulfonate

Remimazolam benzenesulfonate is a GABA agonist.
Target: GABA Receptor
Remimazolam acts on GABA receptor, specifically GABA-alpha. Remimazolam is a new drug innovation in anesthesia. Remimazolam combines the properties of two unique drugs already established in anesthesia - Midazolam and remifentanil. Remimazolam acts on GABA receptors like midazolam and has organ-independent metabolism like remifentanil. Remimazolam is likely to be the sedative of the future, as preliminary phase II trials have shown minimal residual effects on prolonged infusions. Remimazolam has potential to be used as a sedative in ICU and as a novel agent for procedural sedation.

[1]. Goudra BG, et al. Remimazolam: The future of its sedative potential. Saudi J Anaesth. 2014 Jul;8(3):388-391.

Related Products
  • CAS No. :56287-74-2
    Product Name:


    Cat No: I004100 View details
  • CAS No. :40709-69-1
    Product Name:

    (-)-Bicuculline methiodide

    Cat No: I010566 View details
  • CAS No. :125464-42-8
    Product Name:


    Cat No: R026139 View details
  • CAS No. :733717-87-8
    Product Name:


    Cat No: I009406 View details